Atlas Trials

MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance

Clinical trial NCT05722093 · UNKNOWN

Trial details

NCT number
NCT05722093
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19
Start date
2023-06-01
Primary completion
2026-05-31
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.